ACTRN12620000718943尚未招募未知
Cannabinoid Medicine Observational Study (CMOS): A prospective, open-label, observational study of cannabinoid prescribing and dosage patterns in Australian clinical practice.
Applied Cannabis Research0 个研究点目标入组 20,000 人开始时间: 2020年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Seeking or already receiving medicinal cannabis therapy and deemed eligible for medicinal cannabis prescription by their treating physician.
排除标准
- •1.Any severe cognitive, intellectual disability, medical or psychiatric condition that impairs the participant’s ability to provide informed consent
- •2.Females who are pregnant or breastfeeding.
研究者
相似试验
进行中（未招募）
2 期
Clinical research with cannabinoids low doses to treat Alzheimer's diseaseG00-G99Alzheimer's diseaseRBR-4cs7kjzniversidade Federal da Integração Latino-Americana
尚未招募
1 期
Cannabidiol on beyond-Seizure outcomes in children and adults with Developmental and Epileptic EncephalopathyNeurological - EpilepsyEpilepsyACTRN12624000888561Hunter New England Local Health District20
进行中（未招募）
不适用
on-interventional study of a therapeutic cannabinoid magistral preparation for chronic pain symptoms (DETECT Pain)M54F45.41R52M53M79DorsalgiaPain, not elsewhere classifiedOther dorsopathies, not elsewhere classifiedOther soft tissue disorders, not elsewhere classifiedDRKS00027994CannaXan GmbH200
进行中（未招募）
2 期
Evaluation of the efficacy and safety of medicinal cannabis in children with autismAutism Spectrum DisorderRBR-5wr2cqqniversidade Federal da Paraíba
尚未招募
2 期
Investigating the effect of medicinal cannabis on the symptoms and side effects of chemotherapy in people with cancer.cancerACTRN12622000419763Central Adelaide Local Health Network (CALHN)176